semaglutide efficacy weight loss Day 2: Wegovy (Semaglutide 2.4 mg weekly injection) Class: GLP-1 receptor agonist Avg Loss: ~15% of baseline weight Dosing: Weekly subcutaneous injection FDA Approved: June 2021 for chronic weight management Pros Two-year effects of semaglutide in

Treatment recommendations are based on each patients health history, goals, and response to therapy

5 According to Bao et al ., the intervention in NCDs depends on identifying, preventing, and controlling modifiable behavioral risk factors such as smoking, diabetes, hypertension, overweight, and alcohol use

As a result, in-vivo concentrations may fall below thresholds required to reproduce potent mechanistic effects demonstrated in vitro

They increase levels of brain chemicals such as serotonin, dopamine, and norepinephrine, which influence appetite, mood, and impulse control

According to the National Family Health Survey (NFHS-5) 2019-21, obesity is increasing, with 6.5% of Indian adults classified as obese